Serum squamous cell carcinoma antigen as an early indicator of response during therapy of cervical cancer
Stephanie Markovina(Washington University in St. Louis), Perry W. Grigsby(Washington University in St. Louis)
Cited by 73
Related Papers
Thyroid Carcinoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2022|507
SERPINB3 (SCCA1) inhibits cathepsin L and lysoptosis, protecting cervical cancer cells from chemoradiation
|Communications Biology|2022|30
NCCN Guidelines® Insights: Thyroid Carcinoma, Version 1.2025
|Journal of the National Comprehensive Cancer Network|2025|30